POINT-COUNTERPOINT: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? POINT: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; two promising combinations--no definite conclusions
暂无分享,去创建一个
P. Koper | J. Zee | C. Burger | L. Lutgens
[1] S Sawada,et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. , 2001, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[2] P. Grigsby,et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] A. Hart,et al. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.
[4] B N Bundy,et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] B N Bundy,et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. , 1999, The New England journal of medicine.
[6] P J Eifel,et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.
[7] G. Thomas. Improved treatment for cervical cancer--concurrent chemotherapy and radiotherapy. , 1999, The New England journal of medicine.
[8] B N Bundy,et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. , 1999, The New England journal of medicine.
[9] D. Petereit,et al. Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule? , 1999, International journal of radiation oncology, biology, physics.
[10] J. Fowler,et al. The adverse effect of treatment prolongation in cervical carcinoma. , 1995, International journal of radiation oncology, biology, physics.
[11] B. Jeremic,et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] P. Grigsby,et al. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. , 2001, International journal of radiation oncology, biology, physics.
[13] P. Eifel. Chemoradiation for Carcinoma of the Cervix: Advances and Opportunities , 2000, Radiation research.
[14] G. Calais,et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.
[15] F. Fang,et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). , 1998, International journal of radiation oncology, biology, physics.
[16] F. Stewart,et al. Early and late damage in the mouse bladder after radiation combined with cyclophosphamide or cisplatinum, evaluated by two different functional assays. , 1993, Acta oncologica.
[17] M. Hauer-Jensen. Late radiation injury of the small intestine. Clinical, pathophysiologic and radiobiologic aspects. A review. , 1990, Acta oncologica.